Chapter 1 Periodic Paralysis

Advances in Genetics

Volumn 63, Issue , 2008, Pages 3-23

  Fontaine, Bertrand ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL;

GENETICS; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; METABOLISM; MUSCLE; MUTATION; PATHOLOGY; PERIODIC PARALYSIS; REVIEW;

HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; ION CHANNELS; MUSCLES; MUTATION; PARALYSES, FAMILIAL PERIODIC; PARALYSIS, HYPERKALEMIC PERIODIC;

EID: 58949083843     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(08)01001-8     Document Type: Review

References (85)

1. Abbott G.W., Butler M.H., Bendahhou S., Dalakas M.C., Ptacek L.J., and Goldstein S.A. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104 2 (2001) 217-231
2. Bendahhou S., Fournier E., Sternberg D., Bassez G., Furby A., Sereni C., Donaldson M.R., Larroque M.M., Fontaine B., and Barhanin J. In vivo and in vitro functional characterization of Andersen's syndrome mutations. J. Physiol. 565 Pt. 3 (2005) 731-741
3. Bradley W.G., Taylor R., Rice D.R., Hausmanowa-Petruzewicz I., Adelman L.S., Jenkison M., Jedrzejowska H., Drac H., and Pendlebury W.W. Progressive myopathy in hyperkalemic periodic paralysis. Arch. Neurol. 47 9 (1990) 1013-1017
4. Brancati F., Valente E.M., Davies N.P., Sarkozy A., Sweeney M.G., LoMonaco M., Pizzuti A., Hanna M.G., and Dallapiccola B. Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: Broadening the clinical spectrum associated with the T704M mutation in SCN4A. J. Neurol. Neurosurg. Psychiatry 74 9 (2003) 1339-1341
5. Bulman D.E., Scoggan K.A., van Oene M.D., Nicolle M.W., Hahn A.F., Tollar L.L., and Ebers G.C. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53 9 (1999) 1932-1936
6. Buruma O.J., and Bots G.T. Myopathy in familial hypokalaemic periodic paralysis independent of paralytic attacks. Acta Neurol. Scand. 57 2 (1978) 171-179
7. Buruma O.J.S., and Schipperheyn J.J. Periodic paralysis. In: Vinken P.J., and Bruyn G.W. (Eds). Handbook of Clinical Neurology (1979), North-Holland Publishing Company, Amsterdam 147-174
8. Caciotti A., Morrone A., Domenici R., Donati M.A., and Zammarchi E. Severe prognosis in a large family with hypokalemic periodic paralysis. Muscle Nerve 27 2 (2003) 165-169
9. Cannon S.C. Pathomechanisms in channelopathies of skeletal muscle and brain. Annu. Rev. Neurosci. 29 (2006) 387-415
10. Cannon S.C., and Strittmatter S.M. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron 10 2 (1993) 317-326
11. Cannon S.C., Brown Jr. R.H., and Corey D.P. Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels. Biophys. J. 65 1 (1993) 270-288
12. Carle T., Lhuillier L., Luce S., Sternberg D., Devuyst O., Fontaine B., and Tabti N. Gating defects of a novel Na(+) channel mutant causing hypokalemic periodic paralysis. Biochem. Biophys. Res. Commun. 348 2 (2006) 653-661
13. Chinnery P.F., Walls T.J., Hanna M.G., Bates D., and Fawcett P.R. Normokalemic periodic paralysis revisited: Does it exist?. Ann. Neurol. 52 2 (2002) 251-252
14. Cummins T.R., and Sigworth F.J. Impaired slow inactivation in mutant sodium channels. Biophys. J. 71 1 (1996) 227-236
15. Dalakas M.C., and Engel W.K. Treatment of "permanent" muscle weakness in familial Hypokalemic Periodic Paralysis. Muscle Nerve 6 3 (1983) 182-186
16. Davies N.P., Sutton I., Winer J.B., Moorcroft P., Pall H.S., Cole T., Davies M.B., Valente E.M., Brancati F., Hammans S.R., and Hanna M.G. The sodium channel syndromes: Expanding the phenotype associated with SCN4A mutations. J. Neurol. Neurosurg. Psychiatry 73 (2002) 229
17. Dias Da Silva M.R., Cerutti J.M., Arnaldi L.A., and Maciel R.M. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J. Clin. Endocrinol. Metab. 87 11 (2002) 4881-4884
18. Elbaz A., Vale-Santos J., Jurkat-Rott K., Lapie P., Ophoff R.A., Bady B., Links T.P., Piussan C., Vila A., Monnier N., et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): Genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am. J. Hum. Genet. 56 2 (1995) 374-380
19. Engel A.G. Electron microscopic observations in primary hypokalemic and thyrotoxic periodic paralyses. Mayo Clin. Proc. 41 11 (1966) 797-808
20. Engel A.G. Evolution and content of vacuoles in primary hypokalemic periodic paralysis. Mayo Clin. Proc. 45 11 (1970) 774-814
21. Engel A.G., and Lambert E.H. Calcium activation of electrically inexcitable muscle fibers in primary hypokalemic periodic paralysis. Neurology 19 9 (1969) 851-858
22. Feero W.G., Wang J., Barany F., Zhou J., Todorovic S.M., Conwit R., Galloway G., Hausmanowa-Petrusewicz I., Fidzianska A., Arahata K., et al. Hyperkalemic periodic paralysis: Rapid molecular diagnosis and relationship of genotype to phenotype in 12 families. Neurology 43 4 (1993) 668-673
23. Fontaine B., Khurana T.S., Hoffman E.P., Bruns G.A., Haines J.L., Trofatter J.A., Hanson M.P., Rich J., McFarlane H., Yasek D.M., et al. Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science 250 4983 (1990) 1000-1002
24. Fontaine B., Vale-Santos J., Jurkat-Rott K., Reboul J., Plassart E., Rime C.S., Elbaz A., Heine R., Guimaraes J., Weissenbach J., et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat. Genet. 6 3 (1994) 267-272
25. Fontaine B., Fournier E., Sternberg D., Vicart S., and Tabti N. Hypokalemic periodic paralysis: A model for a clinical and research approach to a rare disorder. Neurotherapeutics 4 2 (2007) 225-232
26. Fouad G., Dalakas M., Servidei S., Mendell J.R., Van den Bergh P., Angelini C., Alderson K., Griggs R.C., Tawil R., Gregg R., Hogan K., Powers P.A., et al. Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul. Disord. 7 1 (1997) 33-38
27. Fournier E., Arzel M., Sternberg D., Vicart S., Laforet P., Eymard B., Willer J.C., Tabti N., and Fontaine B. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann. Neurol. 56 5 (2004) 650-661
28. Griggs R.C., Engel W.K., and Resnick J.S. Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness. Ann. Intern. Med. 73 1 (1970) 39-48
29. Hayward L.J., Sandoval G.M., and Cannon S.C. Defective slow inactivation of sodium channels contributes to familial periodic paralysis. Neurology 52 7 (1999) 1447-1453
30. Hecht M.L., Valtysson B., and Hogan K. Spinal anesthesia for a patient with a calcium channel mutation causing hypokalemic periodic paralysis. Anesth. Analg. 84 2 (1997) 461-464
31. Hogan K. The anesthetic myopathies and malignant hyperthermias. Curr. Opin. Neurol. 11 5 (1998) 469-476
32. Ikeda Y., Abe B., Watanabe M., Shoji M., Fontaine B., Itoyama Y., and Hirai S. A Japanese family of autosomal dominant hypokalemic periodic paralysis with a CACNL1A3 gene mutation. Eur. J. Neurol. 3 (1996) 441-445
33. Jurkat-Rott K., and Lehmann-Horn F. Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation. Neurology 62 6 (2004) 1012-1015
34. Jurkat-Rott K., and Lehmann-Horn F. Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis. Neurotherapeutics 4 2 (2007) 216-224
35. Jurkat-Rott K., Lehmann-Horn F., Elbaz A., Heine R., Gregg R.G., Hogan K., Powers P.A., Lapie P., Vale-Santos J.E., Weissenbach J., et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum. Mol. Genet. 3 8 (1994) 1415-1419
36. Jurkat-Rott K., Mitrovic N., Hang C., Kouzmekine A., Iaizzo P., Herzog J., Lerche H., Nicole S., Vale-Santos J., Chauveau D., Fontaine B., and Lehmann-Horn F. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc. Natl Acad. Sci. USA 97 17 (2000) 9549-9554
37. Kawamura S., Ikeda Y., Tomita K., Watanabe N., and Seki K. A family of hypokalemic periodic paralysis with CACNA1S gene mutation showing incomplete penetrance in women. Intern. Med. 43 3 (2004) 218-222
38. Kelly P., Yang W.S., Costigan D., Farrell M.A., Murphy S., and Hardiman O. Paramyotonia congenita and hyperkalemic periodic paralysis associated with a Met 1592 Val substitution in the skeletal muscle sodium channel alpha subunit-a large kindred with a novel phenotype. Neuromuscul. Disord. 7 2 (1997) 105-111
39. Kim J., Hahn Y., Sohn E.H., Lee Y.J., Yun J.H., Kim J.M., and Chung J.H. Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica. J. Neurol. Neurosurg. Psychiatry 70 5 (2001) 618-623
40. Kung A.W. Clinical review: Thyrotoxic periodic paralysis: A diagnostic challenge. J. Clin. Endocrinol. Metab. 91 7 (2006) 2490-2495
41. Kuntzer T., Flocard F., Vial C., Kohler A., Magistris M., Labarre-Vila A., Gonnaud P.M., Ochsner F., Soichot P., Chan V., and Monnier G. Exercise test in muscle channelopathies and other muscle disorders. Muscle Nerve 23 7 (2000) 1089-1094
42. Lapie P., Goudet C., Nargeot J., Fontaine B., and Lory P. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells. FEBS Lett 382 3 (1996) 244-248
43. Lehmann-Horn F., and Iaizzo P.A. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?. Br. J. Anaesth. 65 5 (1990) 692-697
44. Lehmann-Horn F., Rudel R., and Ricker K. Non-dystrophic myotonias and periodic paralyses. A European Neuromuscular Center Workshop held 4-6 October 1992, Ulm, Germany. Neuromuscul. Disord. 3 2 (1993) 161-168
45. Links T.P. Familial Hypokalemic Periodic Paralysis (1992), Rijksuniversiteit Groningen, Groningen 175
46. Links T.P., and van der Hoeven J.H. Muscle fiber conduction velocity in arg1239his mutation in hypokalemic periodic paralysis. Muscle Nerve 23 2 (2000) 296
47. Links T.P., Zwarts M.J., and Oosterhuis H.J. Improvement of muscle strength in familial hypokalaemic periodic paralysis with acetazolamide. J. Neurol. Neurosurg. Psychiatry 51 9 (1988) 1142-1145
48. Links T.P., Zwarts M.J., Wilmink J.T., Molenaar W.M., and Oosterhuis H.J. Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects. Brain 113 Pt. 6 (1990) 1873-1889
49. Links T.P., Smit A.J., Molenaar W.M., Zwarts M.J., and Oosterhuis H.J. Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects. J. Neurol. Sci. 122 1 (1994) 33-43
50. Links T.P., van der Hoeven J.H., and Zwarts M.J. Surface EMG and muscle fibre conduction during attacks of hypokalaemic periodic paralysis. J. Neurol. Neurosurg. Psychiatry 57 5 (1994) 632-634
51. McManis P.G., Lambert E.H., and Daube J.R. The exercise test in periodic paralysis. Muscle Nerve 9 8 (1986) 704-710
52. Michel P., Sternberg D., Jeannet P.Y., Dunand M., Thonney F., Kress W., Fontaine B., Fournier E., and Kuntzer T. Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders. Muscle Nerve 36 5 (2007) 643-650
53. Miller T.M., Dias Da Silva M.R., Miller H.A., Kwiecinski H., Mendell J.R., Tawil R., McManis P., Griggs R.C., Angelini C., Servidei S., Petajan J., Dalakas M.C., et al. Correlating phenotype and genotype in the periodic paralyses. Neurology 63 9 (2004) 1647-1655
54. Monnier N., Procaccio V., Stieglitz P., and Lunardi J. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Genet. 60 6 (1997) 1316-1325
55. Morrill J.A., and Cannon S.C. Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes. J. Physiol. 520 Pt. 2 (1999) 321-336
56. Okuda S., Kanda F., Nishimoto K., Sasaki R., and Chihara K. Hyperkalemic periodic paralysis and paramyotonia congenita-a novel sodium channel mutation. J. Neurol. 248 11 (2001) 1003-1004
57. Plassart E., Reboul J., Rime C.S., Recan D., Millasseau P., Eymard B., Pelletier J., Thomas C., Chapon F., Desnuelle C., et al. Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: Phenotype to genotype correlations and demonstration of the predominance of two mutations. Eur. J. Hum. Genet. 2 2 (1994) 110-124
58. Plassart E., Eymard B., Maurs L., Hauw J.J., Lyon-Caen O., Fardeau M., and Fontaine B. Paramyotonia congenita: Genotype to phenotype correlations in two families and report of a new mutation in the sodium channel gene. J. Neurol. Sci. 142 1-2 (1996) 126-133
59. Plaster N.M., Tawil R., Tristani-Firouzi M., Canun S., Bendahhou S., Tsunoda A., Donaldson M.R., Iannaccone S.T., Brunt E., Barohn R., Clark J., Deymeer F., et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 4 (2001) 511-519
60. Ptacek L.J., George Jr. A.L., Griggs R.C., Tawil R., Kallen R.G., Barchi R.L., Robertson M., and Leppert M.F. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67 5 (1991) 1021-1027
61. Ptacek L.J., Gouw L., Kwiecinski H., McManis P., Mendell J.R., Barohn R.J., George Jr. A.L., Barchi R.L., Robertson M., and Leppert M.F. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann. Neurol. 33 3 (1993) 300-307
62. Ptacek L.J., Tawil R., Griggs R.C., Engel A.G., Layzer R.B., Kwiecinski H., McManis P.G., Santiago L., Moore M., Fouad G., et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77 6 (1994) 863-868
63. Resnick J.S., Engel W.K., Griggs R.C., and Stam A.C. Acetazolamide prophylaxis in hypokalemic periodic paralysis. N. Engl. J. Med. 278 11 (1968) 582-586
64. Ricker K., Rohkamm R., and Bohlen R. Adynamia episodica and paralysis periodica paramyotonica. Neurology 36 5 (1986) 682-686
65. Rojas C.V., Wang J.Z., Schwartz L.S., Hoffman E.P., Powell B.R., and Brown Jr. R.H. A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis. Nature 354 6352 (1991) 387-389
66. Rudel R., Lehmann-Horn F., Ricker K., and Kuther G. Hypokalemic periodic paralysis: In vitro investigation of muscle fiber membrane parameters. Muscle Nerve 7 2 (1984) 110-120
67. Ruff R.L. Calcium-tension relationships of muscle fibers from patients with periodic paralysis. Muscle Nerve 14 9 (1991) 838-844
68. Ruff R.L. Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current. Neurology 53 7 (1999) 1556-1563
69. Ruff R.L. Slow inactivation: Slow but not dull. Neurology 70 10 (2008) 746-747
70. Sillen A., Sorensen T., Kantola I., Friis M.L., Gustavson K.H., and Wadelius C. Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. Am. J. Med. Genet. 69 1 (1997) 102-106
71. Sternberg D., Maisonobe T., Jurkat-Rott K., Nicole S., Launay E., Chauveau D., Tabti N., Lehmann-Horn F., Hainque B., and Fontaine B. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 124 Pt. 6 (2001) 1091-1099
72. Sternberg D., Tabti N., Fournier E., Hainque B., and Fontaine B. Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis. Neurology 61 6 (2003) 857-859
73. Sugiura Y., Aoki T., Sugiyama Y., Hida C., Ogata M., and Yamamoto T. Temperature-sensitive sodium channelopathy with heat-induced myotonia and cold-induced paralysis. Neurology 54 11 (2000) 2179-2181
74. Tang N.L., Chow C.C., Ko G.T., Tai M.H., Kwok R., Yao X.Q., and Cockram C.S. No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients. Clin. Endocrinol. (Oxf.) 61 1 (2004) 109-112
75. Tawil R., Ptacek L.J., Pavlakis S.G., DeVivo D.C., Penn A.S., Ozdemir C., and Griggs R.C. Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann. Neurol. 35 3 (1994) 326-330
76. Tawil R., McDermott M.P., Brown Jr. R., Shapiro B.C., Ptacek L.J., McManis P.G., Dalakas M.C., Spector S.A., Mendell J.R., Hahn A.F., and Griggs R.C. Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Ann. Neurol. 47 1 (2000) 46-53
77. Torres C.F., Griggs R.C., Moxley R.T., and Bender A.N. Hypokalemic periodic paralysis exacerbated by acetazolamide. Neurology 31 11 (1981) 1423-1428
78. Tricarico D., Servidei S., Tonali P., Jurkat-Rott K., and Camerino D.C. Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis. J. Clin. Invest. 103 5 (1999) 675-682
79. Tricarico D., Barbieri M., and Camerino D.C. Acetazolamide opens the muscular KCa2+ channel: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann. Neurol. 48 3 (2000) 304-312
80. Venance S.L., Jurkat-Rott K., Lehmann-Horn F., and Tawil R. SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide. Neurology 63 10 (2004) 1977
81. Venance S.L., Cannon S.C., Fialho D., Fontaine B., Hanna M.G., Ptacek L.J., Tristani-Firouzi M., Tawil R., and Griggs R.C. The primary periodic paralyses: Diagnosis, pathogenesis and treatment. Brain 129 Pt. 1 (2006) 8-17
82. Vicart S., Sternberg D., Fournier E., Ochsner F., Laforet P., Kuntzer T., Eymard B., Hainque B., and Fontaine B. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology 63 11 (2004) 2120-2127
83. Wagner S., Lerche H., Mitrovic N., Heine R., George A.L., and Lehmann-Horn F. A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity. Neurology 49 4 (1997) 1018-1025
84. Weber M.A., Nielles-Vallespin S., Essig M., Jurkat-Rott K., Kauczor H.U., and Lehmann-Horn F. Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness. Neurology 67 7 (2006) 1151-1158
85. Zwarts M.J., van Weerden T.W., Links T.P., Haenen H.T., and Oosterhuis H.J. The muscle fiber conduction velocity and power spectra in familial hypokalemic periodic paralysis. Muscle Nerve 11 2 (1988) 166-173